Table 3.
Clinical and sociodemographic characteristics of sample
| Suicidal behavior (n = 13) | No suicidal behavior (n = 722) | Prodromal HD cases (n = 735) | Controls (n = 194) | |
|---|---|---|---|---|
| Age at intake, years | 38.9±5.0 | 41.2±9.8 | 41.2±9.7 | 43.7±11.0 |
| Years of education | 14.6±3.5 | 14.4±2.7 | 14.4±2.7 | 14.7±2.7 |
| CAG repeats† | 42.5±1.5 | 42.4±2.6 | 42.4±2.5 | |
| Females | 12 (92.3) | 453 (62.7) | 465 (63.3) | 128 (66.0) |
| Proximity to diagnosis†,‡ | ||||
| Far | 5 (38.5) | 271 (37.7) | 276 (37.8) | |
| Mid | 6 (46.1) | 270 (37.6) | 276 (37.8) | |
| Near | 2 (15.4) | 177 (24.7) | 179 (24.4) |
Data presented as means ± SD or n (%).
Missing data from 4 participants without suicidal behavior.
Based on formula by Langbehn et al. [39] from start of follow-up period.